President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

The Centers for Medicare & Medicaid Services recently began meeting with patients who use the 15 drugs it selected for the ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

President Donald Trump’s executive order, which threatens pharmaceutical companies with targeted retaliation and lawsuits if ...

Organon faces profitability challenges and revenue declines. The valuation appears fair given the weak revenue outlook. See ...

Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' ...

Are you or someone else you know reliant on insulin, chemotherapy drugs or pain killers? Branded prescriptions drugs could ...

Exactly 10 years ago Monday, Donald Trump descended an escalator and announced his run for president, a moment many now see ...

On top of that, an analyst cut his price target on the Denmark-based pharmaceutical company. Novo Nordisk (NYSE: NVO) stock ...

Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.

Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...